Today: 30 June 2026
Browse Category

BSE:524816 1 December 2025

Natco Pharma Share Price Today (1 December 2025): Q2 Results, USFDA Update, Adcock Ingram Deal & 2026 Forecast

Natco Pharma Share Price Today (1 December 2025): Q2 Results, USFDA Update, Adcock Ingram Deal & 2026 Forecast

Mumbai, 1 December 2025 — Natco Pharma Limited is back in the spotlight. The stock is seeing heavy trading, fresh institutional interest and a sharp intraday bounce, even as investors digest softer Q2 FY26 earnings, a recent USFDA inspection in Chennai and a large acquisition in South Africa. As of around 11:05 am IST on 1 December 2025, Natco Pharma was quoted near ₹921 on the NSE, up almost 5% for the day. The stock has traded in a day range of ₹880–923, against a 52‑week band of ₹726.80–1,505, with volume close to 2.95 million shares, according to exchange data compiled by Moneycontrol. Moneycontrol
1 December 2025
··

Stock Market Today

  • Investors Look at Xero, Light & Wonder for Cheap Cash Flow
    June 30, 2026, 12:25 AM EDT. With inflation and credit conditions still in focus, investors are watching companies that churn out cash flow. Xero (ASX:XRO), which makes cloud systems for small businesses, is valued at A$12.3 billion and brings in NZ$2.8 billion revenue. The stock trades at a high P/E ratio and leans on outside capital, but its AI efforts and move into more products point to room to grow. Light & Wonder (ASX:LNW) out of Las Vegas shows up too, pulling US$3.3 billion in sales and posting an A$8.8 billion market cap. Both stocks sit below their calculated fair value on DCF screens, drawing in value players on cash strength instead of market buzz.
Go toTop